Dr. Nicole Basta, Associate Professor at the Department of Epidemiology, Biostatistics and Occupational Health is quoted by Global News.
Dr. Catherine Hankins, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and co-chair of Canada's COVID-19 Immunity Task Force is among the experts quoted by CTV News.
"While some wealthy nations prepare to launch third doses of COVID-19 vaccines to further protect their populations, the rest of the world is still largely unvaccinated, with soaring death rates despite record numbers of vials being produced."
Dr. Joanne Liu, Professor focusing on pandemic and health emergencies at the McGill School of Population and Global Health (SPGH) authored a letter in the French daily newspaper Le Devoir.
Dr. Ananya Tina Banerjee, Assistant Professor at the Department of Epidemiology, Biostatistics and Occupational Health is quoted by CBC.
Dr. Nicole Basta, Associate Professor at the Department of Epidemiology, Biostatistics and Occupational Health is interviewed by the Globe and Mail.
Inégalité vaccinale dans le monde : Entrevue avec la Dre Joanne Liu - Radio-Canada, August 3, 2021
Dr. Joanne Liu, Professor focusing on pandemic and health emergencies at the McGill School of Population and Global Health (SPGH) is interviewed by Radio-Canada on COVID-19 vaccine distribution.
"C'est une chose de donner des vaccins, mais il y a toute la chaîne de distribution (...) présentement il y a des doses de vaccins qui restent sur les tarmacs des aéroports."
Dr. Nicholas King, Associate Professor in the Biomedical Ethics Unit, is among the experts quoted by Global News.
"…Nicholas King, a professor in the bioethics and epidemiology department at Ï㽶ÊÓƵ, said inequalities start to present themselves when travel is determined by the type of vaccine a person received."
.
Dr. Ananya Tina Banerjee, Assistant Professor at the Department of Epidemiology, Biostatistics and Occupational Health is among the experts quoted by the Toronto Star.
"Thousands of AstraZeneca doses are going to waste in this country, at a time when other nations face critical vaccine shortages in their battle against COVID-19."
Dr. Catherine Hankins, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and co-chair of Canada's COVID-19 Immunity Task Force is among the experts quoted by Radio Canada.
Dr. Catherine Hankins, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and co-chair of Canada's COVID-19 Immunity Task Force is among the experts quoted by the National Post.
Dr. Madhukar Pai, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and past McGill Global Health Programs Director, co-authored a recent Toronto Star Opinion piece.
"Watching the monstrous surge of COVID-19 cases in South Asia, South America and the African continent has pushed the global community to act fast, and decisively. This month, Canada said it would provide 100 million doses to low- and middle-income countries as part of the G7 effort to provide one billion doses through global sharing programs."
Dr. Ananya Tina Banerjee, Assistant Professor at the Department of Epidemiology, Biostatistics and Occupational Health is among the experts quoted by the Toronto Star.
Dr. Ananya Tina Banerjee, Assistant Professor at the Department of Epidemiology, Biostatistics and Occupational Health is among the experts quoted by CBC.
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term; however, the longer term case burden and the potential for evolution of viral ‘escape’ from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a study from Ï㽶ÊÓƵ and Princeton University published today in Science.
Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published recently in the , a McGill-led team published the results of a recent survey of 28 experts working in vaccinology.